Select Your Region

We noticed you visit this page from United States. Please select your preferred region to continue

Go to United States (English)
skip to content

Country Selector

Based on your location

Europe

North America

Latin America

Asia-Pacific

Multiple Myeloma

World leader in diagnosis and monitoring of Multiple Myeloma patients.

Multiple Myeloma, also known as Kahler’s disease, is the second most common blood cancer worldwide, with nearly 188,000 new cases diagnosed each year.

Multiple Myeloma is typically diagnosed in older individuals between 65 and 74 years old, but people younger than 50 can also exhibit symptoms.

Over the past two decades, the incidence of multiple myeloma has steadily increased, mainly due to the aging of the global population and improvements in diagnostic practices.To date, the risk factors that trigger the transformation and uncontrolled multiplication of plasma cells are not well known.

Early detection and accurate monitoring are key to improving outcomes and guiding effective management of Multiple Myeloma.

Knowledge & Science

Instruments for diagnosing Multiple Myeloma

NO NEED TO Configure - Automatic content selection of pages based on tags

This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country.

Please contact your local Sebia representative. Information intended for healthcare professionals.
Carefully read the instructions in the reagent package inserts and instrument manuals.